Navigation
Life Science Cluster für Hamburg und Schleswig-Holstein

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
The official opening of the new Eppendorf site in Singapore was done by Dr. Thomas Keller, Senior Vice President Market Region Asia/Pacific/Africa at Eppendorf, Eva van Pelt, Co-Chairman of the Management Board of Eppendorf SE, and Lina Tao, Vice President Bioprocess Sales & Service at Eppendorf. ( Picture: © Eppendorf)

Eppendorf opens new site in Singapore

The globally active Eppendorf Group continues its growth track in Asia in a targeted manner and has opened a new site ...

Read more …
Aurobac will work to shift the strategy related to antibiotic treatment regimens, which at the moment leans heavily on empirical approaches using broad-spectrum and unfocused medicines. (Picture: © stock.adobe.com/Christoph Burgstedt)

Evotec, Boehringer Ingel­heim and bioMérieux cooperate

Evotec SE, Boehringer Ingelheim, a leading research-driven biopharmaceutical company, and bioMérieux, a world leader in in vitro diagnostics, announced today that they have formed a ...

Read more …
Bernard Brandewiede, CEO of Amedon (left) and Dr. Gerrit Schönicke, Managing Director of LKF, close the partnership (Photo: © LKF)

LKF announces partnership with Amedon

Amedon is specialized in developing and delivering web-based solutions for clinical research. More than 18-year experience in eCRF, eTMF and SAE Database makes Amedon an ...

Read more …
Welcome to Hamburg! Second Mayor Katharina Fegebank praises Bayerische Hausbau, MATRIX and Sysmex Europe for investing in new working environments. (Image: © Bayerische Hausbau GmbH & Co. KG)

Groundbreaking for New Work Campus FLOW in Hamburg

The new work campus FLOW in Hamburg is becoming a reality: The MATRIX Group and Bayerische Hausbau laid the foundation stone together with anchor tenant ...

Read more …
The #LifeScienceTour visited altona Diagnostics: State Councilor Andreas Rieckhof talked to Dr Meike Thiel, Dr Ulrich Spengler, Juliane Worm (LSN), Dr Markus Hess and Wilhelm Dreyer (from left)

altona Diagnostics on course for growth

The fact that the pandemic has also given a boost to certain sectors of the economy is particularly noticeable at a company like

Read more …

Sysmex Europe SE is listed in the top 100 best workplaces

Sysmex Europe is proud to announce that Sysmex Europe SE is listed in the top 100 best workplaces by Great Place ...

Read more …

Indivumed Celebrates 20th Anniversary

Indivumed GmbH (“Indivumed”) today celebrated the company’s 20th anniversary milestone. Founded in Hamburg, Germany on April 5, 2002, Indivumed has rapidly expanded to ...

Read more …

LKF is a new member of Life Science Nord e.V.

For more than 30 years, LKF has been supporting research-based pharmaceutical companies and contract research organizations with laboratory services in the context of ...

Read more …

Sysmex Establishes Subsidiary in Saudi Arabia

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announced today the establishment of a new subsidiary, Sysmex LLC, in Saudi Arabia. With this ...

Read more …
The partners are leveraging Evotec's patient database on kidney disease to identify and validate promising novel targets for new therapeutic approaches. (Image: ©Sergey Nivens/stock.adobe.com)

Evotec and Lilly enter into collaboration

Evotec SE announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company (“Lilly”) in the ...

Read more …
Senator of Economics Affairs Michael Westhagemann (left) and Ralf Sommer, CEO of the Hamburg Investment and Development Bank (right) hand over the notification of funding to Indivumed CEO Prof. Dr. Hartmut Juhl (Image: ©BVM)

Accelerated drug development and personalised treatments for cancer

Indivumed GmbH is a biotech company with international activities and representative offices in the US, Japan, Italy and Brasil. It cooperates with numerous international research ...

Read more …
The molecule has shown great potential to produce a powerful antiviral response against infections with SARS-CoV-2. (Picture: ©NicoElNino/adobe.stock.com)

Evotec: € 7.5 m grant for development of COVID-19 therapeutic

Evotec SE announced that the Company has been selected by the German Federal Ministry of Education and Research (“BMBF”) to receive a grant for the ...

Read more …
Job board